|
|
|
4534 Mochida Pharmaceutical Co.,Ltd.
|
|
| 02/06/2026 14:30 |
[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2025 |
| 02/06/2026 14:00 |
Announcement of the Establishment of Mochida Medical USA, Inc. |
| 02/06/2026 14:00 |
Notice Concerning Revisions to Full-Year Consolidated Financial Results Forecasts |
| 12/22/2025 15:30 |
Obtained manufacturing and marketing approval in Japan for Avarept Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient |
| 12/15/2025 14:00 |
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan |
| 11/04/2025 14:00 |
[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 09/22/2025 17:30 |
Notice Concerning Subscription to a Third-Party Allotment of Shares and the Acquisition of Shares of And Pharma Co., Ltd. |
| 08/01/2025 14:00 |
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2025 |
| 06/27/2025 16:00 |
Notice Regarding Approval of the Continuation of the Policy on Large-Scale Share Acquisition and Changes of Special Committee Member |
| 06/02/2025 08:00 |
NOTICE OF THE 87th ORDINARY GENERAL MEETING OF SHAREHOLDERS 2025 |
| 05/12/2025 14:00 |
Continuation of the Policy on Large-Scale Share Acquisition(Takeover Response Policy) |
| 05/12/2025 14:00 |
Notice Concerning Change of Representative Directors and Directors |
| 05/12/2025 14:00 |
[Summary] Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 |
| 02/07/2025 14:00 |
[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2024 |
|
